RECURRENT ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for RECURRENT ADULT ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADULT ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT ADULT ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted radiation may boost second stem cell transplants for relapsed blood cancers
Disease control TerminatedThis study tests adding a precise type of bone marrow radiation (IMTMI) to standard chemotherapy before a second donor stem cell transplant. It is for people with blood cancers like leukemia that have returned after a first transplant. The goal is to find the safest radiation dos…
Matched conditions: RECURRENT ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New CMV strategy aims to protect stem cell transplant patients from dangerous infection
Disease control OngoingThis study looks at a modified approach to prevent and treat cytomegalovirus (CMV) infection in people who have had a donor stem cell transplant for blood cancers or disorders. About 153 participants are involved, and the goal is to see if changing when and how anti-CMV drugs are…
Matched conditions: RECURRENT ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New combo therapy shows promise in controlling tough leukemia
Disease control OngoingThis study looks at a powerful mix of chemotherapy drugs (Hyper-CVAD and dasatinib) for people with a specific genetic type of acute lymphoblastic leukemia (Ph+ ALL). Some participants also receive a donor stem cell transplant. The goal is to see how well this approach controls t…
Matched conditions: RECURRENT ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:49 UTC